11–12 October 2018 Advances in Immuno-Oncology USA Congress
San Diego, USA
Due to the success of the UK Advances in Immuno-Oncology event, Oxford Global are expanding this event to the USA. The USA Congress is the first of its kind and will feature over 20 presentations from leading heads of the Pharmaceutical industry and ensures you will benefit from the latest case studies and high level scientific debate.
Topic discussion ranges across a variety of therapeutic strategies, from CAR T cell therapies to microbiome in Immuno-Oncology and from assays and modelling in Immuno-Oncology to NK cell-based therapeutics.
Further talks look at approaches to clinical trial design and development and Translational Immuno-Oncology. To enhance the interactivity of the program, we have also introduced discussion opportunities through panels, roundtables and workshops on hot topics in this field.
Key speakers include Vice Presidents, Directors and Executives from leading pharmaceutical industries such as Pfizer and Atreca. The two day congress offers the opportunity to have scientific and business discussions, ensuring valuable networking and interactive sessions.
The conference will bring together over 100 senior industry experts and key opinion leaders in Immuno-Oncology.
Free Pre-Congress Live Webinar
The Role For TNFR2 In The Tumor Microenvironment
Hosted by Russell LaMontagne, Chief Executive Officer, Boston Immune Technologies and Therapeutics Inc
- The role TNFR2 tregs
- TNFR2 Oncogene
- Novel TNFR2 antibodies
Why should you attend this webinar?
- Get an in-depth overview of the RWE landscape in Europe
- Hear key updates from IMI EMIF
- Discuss collaboration in this growing area
Register for free today